EIKN
Financials
- Market Capitalization 565.21 M
- Employee 384
- Founded 2019
- CEO N/A
- Website www.eikontx.com
- Headquarter Delaware, United States
- FIGI BBG00T0XRJ75
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2058 |  GENB Generate Biomedicines, Inc. - Common Stock | 14.28 USD | -0.35% | -15.65% | +12.89% | -4.80% | 1.83 B USD | ||
| 2140 |  MAZE Maze Therapeutics, Inc. - Common Stock | 29.18 USD | -4.55% | -10.22% | +19.93% | -35.20% | 1.61 B USD | ||
| 3024 |  CBIO Crescent Biopharma, Inc. - Common Stock | 15.69 USD | -9.52% | -7.16% | -12.00% | +22.58% | 432.60 M USD | ||
| 3104 |  UPB Upstream Bio, Inc. - Common Stock | 7.28 USD | -3.32% | -2.67% | +17.61% | -38.31% | 396.18 M USD |
Frequently asked questions about Eikon Therapeutics, Inc. - Common Stock
What is the Eikon Therapeutics, Inc. - Common Stock stock price today?
The current price of Eikon Therapeutics, Inc. - Common Stock (EIKN) is 10.44. Over the past 24 hours, the stock has changed by -1.32%. Follow the EIKN chart for real-time price dynamics.
What is the stock ticker of Eikon Therapeutics, Inc. - Common Stock?
Eikon Therapeutics, Inc. - Common Stock trades under the ticker EIKN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Eikon Therapeutics, Inc. - Common Stock stock going up?
EIKN has changed by -14.14% over the last week, +9.66% over the last month, and -38.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
How many employees does Eikon Therapeutics, Inc. - Common Stock have?
As of the latest available data, Eikon Therapeutics, Inc. - Common Stock has 384 employees. Workforce size can provide additional context about the company's scale and operations.
What is Eikon Therapeutics, Inc. - Common Stock EBITDA?
Eikon Therapeutics, Inc. - Common Stock EBITDA is -78.57 M, and its EBITDA margin is -1 793.84%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Eikon Therapeutics, Inc. - Common Stock stock?
You can buy Eikon Therapeutics, Inc. - Common Stock (EIKN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Eikon Therapeutics, Inc. - Common Stock stock?
Investing in Eikon Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EIKN chart and related analysis on metatrader.com as part of your research.